Staphylococcus aureus isolates encode variant staphylococcal enterotoxin B proteins that are diverse in superantigenicity and lethality

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Kohler, Petra L ^a   Greenwood, Seth D ^a   Nookala, Suba ^b   Kotb, Malak ^b   Kranz, David M ^c   Schlievert, Patrick M ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOKINE; PROTEIN VARIANT; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS ENTEROTOXIN C; STAPHYLOCOCCUS ENTEROTOXIN C1; STAPHYLOCOCCUS ENTEROTOXIN C2; STAPHYLOCOCCUS ENTEROTOXIN C3; STAPHYLOCOCCUS ENTEROTOXIN C4; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ANTIGEN PRESENTING CELL; ANTIGENICITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE SEQUENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LETHALITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PROTEIN PURIFICATION; SEB GENE; SPLEEN CELL; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TOXIC SHOCK SYNDROME;

AMINO ACID SEQUENCE; ANIMALS; CELL PROLIFERATION; CLONING, MOLECULAR; ENTEROTOXINS; GENES, T-CELL RECEPTOR BETA; GENETIC VARIATION; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; RABBITS; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS;

EID: 84863992210     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041157     Document Type: Article

References (33)

1. McCormick JK, Yarwood JM, Schlievert PM, (2001) Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55: 77-104.
2. Marrack P, Kappler J, (1990) The staphylococcal enterotoxins and their relatives. Science 248: 1066.
3. Kappler J, Kotzin B, Herron L, Gelfand EW, Bigler RD, et al. (1989) V beta-specific stimulation of human T cells by staphylococcal toxins. Science 244: 811-813.
4. Kotzin BL, Leung DY, Kappler J, Marrack P, (1993) Superantigens and their potential role in human disease. Adv Immunol 54: 99-166.
5. Schlievert PM, Case LC, Strandberg KL, Abrams BB, Leung DY, (2008) Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clin Infect Dis 46: 1562-1567.
6. Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY, (2010) Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 125: 39-49.
7. Pragman AA, Yarwood JM, Tripp TJ, Schlievert PM, (2004) Characterization of virulence factor regulation by SrrAB, a two-component system in Staphylococcus aureus. J Bacteriol 186: 2430-2438.
8. Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD, (1981) Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis 143: 509-516.
9. Schlievert PM, Tripp TJ, Peterson ML, (2004) Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J Clin Microbiol 42: 2875-2876.
10. Schlievert PM, (1986) Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1: 1149-1150.
11. Crass BA, Bergdoll MS, (1986) Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome. J Clin Microbiol 23: 1138-1139.
12. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP, (1981) A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1: 1017-1021.
13. CDC (1999) From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA 282: 1123-1125.
14. Chi YI, Sadler I, Jablonski LM, Callantine SD, Deobald CF, et al. (2002) Zinc-mediated dimerization and its effect on activity and conformation of staphylococcal enterotoxin type C. J Biol Chem 277: 22839-22846.
15. Papageorgiou AC, Acharya KR, Shapiro R, Passalacqua EF, Brehm RD, et al. (1995) Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure 3: 769-779.
16. Papageorgiou AC, Tranter HS, Acharya KR, (1998) Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J Mol Biol 277: 61-79.
17. Yarwood JM, McCormick JK, Paustian ML, Orwin PM, Kapur V, et al. (2002) Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. J Biol Chem 277: 13138-13147.
18. Poindexter NJ, Schlievert PM, (1985) Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes. J Infect Dis 151: 65-72.
19. Schlievert PM, (1982) Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C. Infect Immun 36: 123-128.
20. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493-497.
21. Baker MD, Papageorgiou AC, Titball RW, Miller J, White S, et al. (2002) Structural and functional role of threonine 112 in a superantigen Staphylococcus aureus enterotoxin B. J Biol Chem 277: 2756-2762.
22. Kappler JW, Herman A, Clements J, Marrack P, (1992) Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med 175: 387-396.
23. Komisar JL, Small-Harris S, Tseng J, (1994) Localization of binding sites of staphylococcal enterotoxin B (SEB), a superantigen, for HLA-DR by inhibition with synthetic peptides of SEB. Infect Immun 62: 4775-4780.
24. Garcia C, Briggs C, Zhang L, Guan L, Gabriel JL, et al. (1998) Molecular characterization of the putative T-cell receptor cavity of the superantigen staphylococcal enterotoxin B. Immunology 94: 160-166.
25. Briggs C, Garcia C, Zhang L, Guan L, Gabriel JL, et al. (1997) Mutations affecting the superantigen activity of staphylococcal enterotoxin B. Immunology 90: 169-175.
26. Neill RJ, Jett M, Crane R, Wootres J, Welch C, et al. (1996) Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures. Infect Immun 64: 3007-3015.
27. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, et al. (1994) Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368: 711-718.
28. Li H, Llera A, Tsuchiya D, Leder L, Ysern X, et al. (1998) Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity 9: 807-816.
29. Wang X, Zhang H, Xu M, Cai Y, Liu C, et al. (2009) Biological characterization of the zinc site coordinating histidine residues of staphylococcal enterotoxin C2. Microbiology 155: 680-686.
30. Buonpane RA, Churchill HR, Moza B, Sundberg EJ, Peterson ML, et al. (2007) Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med 13: 725-729.
31. Thomas D, Dauwalder O, Brun V, Badiou C, Ferry T, et al. (2009) Staphylococcus aureus superantigens elicit redundant and extensive human Vbeta patterns. Infect Immun 77: 2043-2050.
32. Brosnahan AJ, Schlievert PM, (2011) Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome. FEBS J 278: 4649-4667.
33. Lee PK, Kreiswirth BN, Deringer JR, Projan SJ, Eisner W, et al. (1992) Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus. J Infect Dis 165: 1056-1063.